| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.07B | 6.32B | 4.92B | 4.80B | 4.88B | 4.50B |
| Gross Profit | 3.49B | 3.71B | 3.35B | 3.29B | 3.48B | 3.12B |
| EBITDA | 1.61B | 1.74B | 1.68B | 1.69B | 1.80B | 1.66B |
| Net Income | 906.67M | 625.40M | 992.08M | 1.06B | 1.11B | 1.01B |
Balance Sheet | ||||||
| Total Assets | 6.50B | 7.10B | 6.94B | 6.08B | 5.55B | 5.03B |
| Cash, Cash Equivalents and Short-Term Investments | 3.58B | 4.59B | 4.08B | 3.69B | 3.06B | 3.31B |
| Total Debt | 186.63M | 170.00M | 196.66M | 100.00M | 100.00M | 100.00M |
| Total Liabilities | 1.14B | 1.29B | 1.29B | 894.69M | 899.14M | 911.14M |
| Stockholders Equity | 5.36B | 5.80B | 5.66B | 5.19B | 4.65B | 4.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.09B | 1.13B | 1.20B | 799.80M | 1.08B |
| Operating Cash Flow | 0.00 | 1.13B | 1.21B | 1.31B | 899.36M | 1.15B |
| Investing Cash Flow | 0.00 | -121.97M | -212.46M | -164.90M | -1.11B | -119.11M |
| Financing Cash Flow | 0.00 | -558.78M | -632.15M | -596.66M | -576.43M | -504.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥13.68B | 16.82 | ― | 4.27% | 28.58% | -36.26% | |
77 Outperform | ¥673.16B | 23.13 | 32.41% | 3.62% | 20.01% | -6.20% | |
75 Outperform | ¥30.63B | 21.60 | ― | 0.38% | 19.28% | 113.67% | |
70 Outperform | ¥43.74B | 34.67 | ― | ― | 27.05% | 495.56% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥9.11B | -5.91 | 4.78% | ― | -8.38% | -78.30% |